“…In addition, except the upregulation of mRNA expressions of Wnt1, Wnt3a, LRP5 and β-catenin in tissue derived mesenchymal stem cells (ADSCs), PEMFs intervention could also reduce the expression of dickkopf1 (DKK1) which usually acts as an inhibitor of Wnt signaling pathway [32]. Furthermore, the enhanced Wnt/β-catenin signaling induced by PEMFs notably elevated the expression of proliferation phase related target genes, Ccnd 1 and Ccne 1, and differentiation phase related genes, ALP, OCN, COL1, and Runx2, in osteoblast cells, which accelerated the osteoblasts proliferation, differentiation, and mineralization, three pivotal processes of bone formation [31, 32]. On the other hand, according to in vivo assay studies, PEMFs effectively reversed the bone mass loss and deterioration of bone microarchitecture analyzed by microCT and attenuated biomechanical strength deterioration evaluated by three-point bending test in hind limb-suspended ovariectomized rats through the Wnt/Lrp5/β-catenin signal pathway [33, 34], indicating that activating this pathway by PEMF exposure is beneficial for bone disorders.…”